Cancer News and Research

RSS

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Ribo-seq Optimization to Gain Insights into Protein Production

Ribosome profiling, a gene sequencing approach, has increased the understanding of the human genome by uncovering previously undiscovered protein-coding regions.

22 Sep 2023

How Scientists are Using iPSCs to Develop New Therapies

In 1998, scientists reported being able to derive cells from human embryos that could develop into almost any cell in the body. In 2007, the field took a huge leap when scientists discovered they could reprogram human adult skin cells to act like these embryonic stem cells.

20 Sep 2023

Pre-Targeted Radioimmunotherapy System Cures Fatal Ovarian Cancer in Preclinical Study

A new 225Ac-DOTA-based pre-targeted radioimmunotherapy (PRIT) system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects.

19 Sep 2023

Key Proteins in Human Breast Milk Crucial for Baby’s Healthy Gut

The abundance of two species of bacteria known to be good for human health and used as probiotics, Clostridium butyricum and Parabacteroides distasonis, has been linked to high concentrations of key proteins in human breast milk, particularly osteopontin and κ-casein.

13 Sep 2023

The Intriguing Phenomenon of Cellular Reprogramming

A fascinating phenomenon of cellular reprogramming in developed adult organs has been revealed by researchers, providing insight into a brand-new process of adaptive development.

12 Sep 2023

Iron-Targeting Compounds Hamper Proliferation of Cancer Cells

Scientists at the University of Arizona Cancer Center have made a breakthrough by uncovering a novel category of compounds that target iron, impeding the growth of malignant cells cultured in a laboratory environment.

12 Sep 2023

The First Microrobots Capable of Navigating Within Groups of Cells and Stimulating Individual Cells

A group of researchers at the Technical University of Munich (TUM) has developed the world's first microrobot ("microbot") capable of navigating within groups of cells and stimulating individual cells.

12 Sep 2023

Developing a Microfluidic Device that Captures Circulating Tumor Cells

In the book titled “Microfluidic Systems for Cancer Diagnosis,” the UPV/EHU’s Microfluidics Cluster group outlines a method for constructing a bioelectronic device.

11 Sep 2023

Canine DNA Database Provides Unprecedented Look at Dog Evolution

A global collaboration of scientists is leveraging an exceptionally extensive canine DNA database to conduct an impartial exploration into the evolutionary processes that have given rise to the diverse breeds of our canine companions.

8 Sep 2023

Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer

The electrochemical sensor, made of a graphitic nano-onion/molybdenum disulfide nanosheet composite, detects human papillomavirus (HPV)-16 and HPV-18, with high specificity.

8 Sep 2023

Immune Cells Can Create Their Own Chemical Cues to Navigate

In a breakthrough finding, Jonna Alanko, a researcher from InFLAMES, has unveiled that immune cells are not mere passive followers of chemical signals in their surroundings.

7 Sep 2023

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

llumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., as Chief Executive Officer, effective September 25, 2023.

5 Sep 2023

Targeted MicroRNA-34a Therapy Shows Promise in Slowing Tumor Growth in Mice

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.

5 Sep 2023

New Insights Into How Cells Maintain Optimal Health

A group of researchers has unearthed the secrets behind a tiny but crucial protein that shuttles zinc ions (Zn2+) within our bodies. The discovery offers a deeper understanding of how our cells maintain optimal health.

4 Sep 2023

LJI Scientists Harness 'Helper' T Cells To Treat Tumors

Scientists are on the hunt for a unique set of mutations, called "neoantigens," that let the immune system distinguish tumor cells from normal cells. Their goal is to help the immune system react to neoantigens and target tumor cells for destruction.

4 Sep 2023

New Gene Therapy Shows Promise in Treating Gliomas

The University of Michigan Department of Neurosurgery and Rogel Cancer Center study demonstrates enticing early results that a therapy merging cell-killing and immune-stimulating drugs is effective and safe in prolonging survival for patients with gliomas, an extremely aggressive form of brain cancer.

1 Sep 2023

Case Western Reserve Biochemists Find New Approach to Stop Cancer Growth

Case Western Reserve University biochemical researchers have identified a new function of a key protein that leads to cancer–a finding they believe could lead to more effective treatments for a range of cancers and other diseases.

1 Sep 2023

Newly Discovered Fungus Helps Destroy a Harmful Food Toxin

Patulin is a harmful mycotoxin produced by fungi typically found in damaged fruits, including apples, pears, and grapes.

1 Sep 2023

MAGE Technology Helps Reveal the Potency of Antibiotics

By substituting each of the 20 amino acid alternatives found in nature for one of the 38 amino acid components that make up the rifampicin binding site on E. coli, the study authors were able to produce 760 distinct RNAP mutants. The development of this mutant pool was then examined under various circumstances, including rifampicin therapy.

31 Aug 2023

Crick Researchers Identify Stem Cells in Thymus for First Time

For the first time, Francis Crick Institute researchers have discovered stem cells in the human thymus. These cells provide a possible new target for research into immunological disorders, cancer, and immune system stimulation.

31 Aug 2023